F-18 FDG uptake due to acinetobacter infection causing misinterpretation of treatment response in a lymphoma patient.
Yildiz
Ramazan
R
Departments of Medical Oncology, Gazi Hospital, Gazi University School of Medicine, 06500 Besevler/Ankara, Turkey. ryildiz@gazi.edu.tr
Coskun
Ugur
U
Kapucu
Ozlem
O
Kaya
Ali Osman
AO
Akdemir
Umit Ozgur
UO
Benekli
Mustafa
M
Buyukberber
Suleyman
S
D000151:Acinetobacter Infections / Q000000981:diagnostic imaging*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001999:Bronchoscopy; D003520:Cyclophosphamide / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D019788:Fluorodeoxyglucose F18 / Q000493:pharmacokinetics*; D006801:Humans; D008171:Lung Diseases / Q000000981:diagnostic imaging* / Q000382:microbiology; D016393:Lymphoma, B-Cell / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics*; D014055:Tomography, Emission-Computed; D014057:Tomography, X-Ray Computed; D014750:Vincristine / Q000627:therapeutic use
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone